Advertisement

Milrinone Injection

[02 February 2016]

Products Affected - Description

Milrinone injection, Fresenius Kabi 
1 mg/mL, 20 mL vial, 10 count (NDC 63323-0617-20)
 
Milrinone injection, West-Ward
0.2 mg/mL, 100 mL premixed bag, 10 count (NDC 00143-9719-10)
0.2 mg/mL, 200 mL premixed bag, 10 count (NDC 00143-9718-10)
1 mg/mL, 50 mL vial, 1 count (NDC 00143-9708-01)

Reason for the Shortage

  • Fresenius Kabi states the reason for the shortage is increased demand for the product.
  • Hospira has milrinone injection on shortage due to increased demand.
  • West-Ward states the shortage is due to manufacturing delays.

Available Products

Milrinone injection, Baxter
0.2 mg/mL, 100 mL premixed bags, 10 count (NDC 00338-6010-48)
0.2 mg/mL, 200 mL premixed bags, 10 count (NDC 00338-6011-37)
 
Milrinone injection, Fresenius Kabi
1 mg/mL, 10 mL vial, 10 count (NDC 63323-0617-10)
1 mg/mL, 50 mL vial, 1 count (NDC 63323-0617-50)
 
Milrinone injection, Hospira
0.2 mg/mL, 100 mL premixed bag, 10 count (NDC 00409-2776-23)
0.2 mg/mL, 200 mL premixed bag, 10 count (NDC 00409-2776-02)
1 mg/mL, 10 mL vial, 10 count (NDC 00409-0212-01)
1 mg/mL, 20 mL vial, 10 count (NDC 00409-0212-02)
1 mg/mL, 50 mL vial, 1 count (NDC 00409-0212-03)
 
Milrinone injection, West-Ward
1 mg/mL, 10 mL vial, 10 count (NDC 00143-9710-10)
1 mg/mL, 20 mL vial, 10 count (NDC 00143-9709-10)

Estimated Resupply Dates

  • Fresenius Kabi has milrinone 1 mg/mL 20 mL vials on back order and the company estimates a release date of early-February 2016.
  • West-Ward has milrinone 1 mg/mL 50 mL vials on a weekly allocation. Milrinone 0.2 mg/mL 100 mL and 200 mL premixes are also on a weekly allocation.

Related Shortages

Updated

February 2, January 27 and 14, 2016; December 29 and 3, November 17 and 3, October 19, 12 and 5, September 22, August 24, July 29 and 8, June 17, May 19, April 29, February 19, January 30, 2015; December 18 and 1, November 14 and 5, October 2, September 10, August 14, July 17, May 30 and 19, April 30, 16 and 1, March 11, February 14, January 21, 2014; December 12, November 26, October 24, September 12, August 26 and 14, July 9, June 20, May 8, April 19 and 1, February 7, 2013; December 12, November 15, October 2, September 12, July 26, June 21, May 25, April 27, March 22, February 17, January 13, 2012; December 22, November 11, October 27, September 23, August 26, July 29, May 23, April 28, March 23, 2011, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement